These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27885461)
1. Prevention and treatment effect of evogliptin on hepatic steatosis in high-fat-fed animal models. Kim MK; Chae YN; Ahn GJ; Shin CY; Choi SH; Yang EK; Sohn YS; Son MH Arch Pharm Res; 2017 Feb; 40(2):268-281. PubMed ID: 27885461 [TBL] [Abstract][Full Text] [Related]
2. Hepatic role in an early glucose-lowering effect by a novel dipeptidyl peptidase 4 inhibitor, evogliptin, in a rodent model of type 2 diabetes. Kim TH; Kim MK; Cheong YH; Chae YN; Lee Y; Ka SO; Jung IH; Shin CY; Bae EJ; Son MH Eur J Pharmacol; 2016 Jan; 771():65-76. PubMed ID: 26621343 [TBL] [Abstract][Full Text] [Related]
3. Effects of sitagliptin on nonalcoholic fatty liver disease in diet-induced obese rats. Akaslan SB; Degertekin CK; Yilmaz G; Cakir N; Arslan M; Toruner FB Metab Syndr Relat Disord; 2013 Aug; 11(4):243-50. PubMed ID: 23544853 [TBL] [Abstract][Full Text] [Related]
4. Beneficial Effects of Evogliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, on Adiposity with Increased Ppargc1a in White Adipose Tissue in Obese Mice. Chae YN; Kim TH; Kim MK; Shin CY; Jung IH; Sohn YS; Son MH PLoS One; 2015; 10(12):e0144064. PubMed ID: 26633898 [TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase-4 inhibition ameliorates Western diet-induced hepatic steatosis and insulin resistance through hepatic lipid remodeling and modulation of hepatic mitochondrial function. Aroor AR; Habibi J; Ford DA; Nistala R; Lastra G; Manrique C; Dunham MM; Ford KD; Thyfault JP; Parks EJ; Sowers JR; Rector RS Diabetes; 2015 Jun; 64(6):1988-2001. PubMed ID: 25605806 [TBL] [Abstract][Full Text] [Related]
6. Piperine reverses high fat diet-induced hepatic steatosis and insulin resistance in mice. Choi S; Choi Y; Choi Y; Kim S; Jang J; Park T Food Chem; 2013 Dec; 141(4):3627-35. PubMed ID: 23993530 [TBL] [Abstract][Full Text] [Related]
7. MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice. Ohyama T; Sato K; Yamazaki Y; Hashizume H; Horiguchi N; Kakizaki S; Mori M; Kusano M; Yamada M World J Gastroenterol; 2014 Nov; 20(43):16227-35. PubMed ID: 25473177 [TBL] [Abstract][Full Text] [Related]
8. Protective Effects of Evogliptin on Steatohepatitis in High-Fat-Fed Mice. Kim JH; Jang SJ; Roh GS; Cho HS; Kang H; Kim SK Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937958 [TBL] [Abstract][Full Text] [Related]
9. Fructose supplementation worsens the deleterious effects of short-term high-fat feeding on hepatic steatosis and lipid metabolism in adult rats. Crescenzo R; Bianco F; Coppola P; Mazzoli A; Tussellino M; Carotenuto R; Liverini G; Iossa S Exp Physiol; 2014 Sep; 99(9):1203-13. PubMed ID: 24972835 [TBL] [Abstract][Full Text] [Related]
10. A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. Hwang HJ; Jung TW; Kim BH; Hong HC; Seo JA; Kim SG; Kim NH; Choi KM; Choi DS; Baik SH; Yoo HJ Biochem Pharmacol; 2015 Nov; 98(1):157-66. PubMed ID: 26297911 [TBL] [Abstract][Full Text] [Related]
11. Additive effects of evogliptin in combination with pioglitazone on fasting glucose control through direct and indirect hepatic effects in diabetic mice. Kim TH; Lee JH; Chae YN; Jung IH; Kim MK Eur J Pharmacol; 2018 Jul; 830():95-104. PubMed ID: 29727638 [TBL] [Abstract][Full Text] [Related]
12. Seabuckthorn Leaves Extract and Flavonoid Glycosides Extract from Seabuckthorn Leaves Ameliorates Adiposity, Hepatic Steatosis, Insulin Resistance, and Inflammation in Diet-Induced Obesity. Kwon EY; Lee J; Kim YJ; Do A; Choi JY; Cho SJ; Jung UJ; Lee MK; Park YB; Choi MS Nutrients; 2017 Jun; 9(6):. PubMed ID: 28574484 [TBL] [Abstract][Full Text] [Related]
13. Mulberry ethanol extract attenuates hepatic steatosis and insulin resistance in high-fat diet-fed mice. Song H; Lai J; Tang Q; Zheng X Nutr Res; 2016 Jul; 36(7):710-8. PubMed ID: 27262537 [TBL] [Abstract][Full Text] [Related]
14. Supplementation with Vitis vinifera L. skin extract improves insulin resistance and prevents hepatic lipid accumulation and steatosis in high-fat diet-fed mice. Santos IB; de Bem GF; Cordeiro VSC; da Costa CA; de Carvalho LCRM; da Rocha APM; da Costa GF; Ognibene DT; de Moura RS; Resende AC Nutr Res; 2017 Jul; 43():69-81. PubMed ID: 28739056 [TBL] [Abstract][Full Text] [Related]
15. Grape pomace reduces the severity of non-alcoholic hepatic steatosis and the development of steatohepatitis by improving insulin sensitivity and reducing ectopic fat deposition in mice. Daniel T; Ben-Shachar M; Drori E; Hamad S; Permyakova A; Ben-Cnaan E; Tam J; Kerem Z; Rosenzweig T J Nutr Biochem; 2021 Dec; 98():108867. PubMed ID: 34571189 [TBL] [Abstract][Full Text] [Related]
16. Dipeptidyl peptidase-4 inhibitor and sodium-glucose cotransporter 2 inhibitor additively ameliorate hepatic steatosis through different mechanisms of action in high-fat diet-fed mice. Iwamoto Y; Kimura T; Dan K; Iwamoto H; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nogami Y; Shirakiya Y; Nakanishi S; Mune T; Kaku K; Kaneto H Diabetes Obes Metab; 2024 Jun; 26(6):2339-2348. PubMed ID: 38504118 [TBL] [Abstract][Full Text] [Related]
17. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice. Yamaguchi K; Nishimura T; Ishiba H; Seko Y; Okajima A; Fujii H; Tochiki N; Umemura A; Moriguchi M; Sumida Y; Mitsuyoshi H; Yasui K; Minami M; Okanoue T; Itoh Y Liver Int; 2015 Feb; 35(2):550-61. PubMed ID: 25066281 [TBL] [Abstract][Full Text] [Related]
18. DA-1229, a novel and potent DPP4 inhibitor, improves insulin resistance and delays the onset of diabetes. Kim MK; Chae YN; Kim HD; Yang EK; Cho EJ; Choi SH; Cheong YH; Kim HS; Kim HJ; Jo YW; Son MH; Kim SH; Shin CY Life Sci; 2012 Jan; 90(1-2):21-9. PubMed ID: 22056373 [TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-like protein 4 improves glucose tolerance and insulin resistance but induces liver steatosis in high-fat-diet mice. Wang Y; Liu LM; Wei L; Ye WW; Meng XY; Chen F; Xiao Q; Chen JY; Zhou Y Mol Med Rep; 2016 Oct; 14(4):3293-300. PubMed ID: 27573470 [TBL] [Abstract][Full Text] [Related]
20. Combined treatment of dipeptidyl peptidase-4 inhibitor and exercise training improves lipid profile in KK/Ta mice. Tanimura Y; Aoi W; Mizushima K; Higashimura Y; Naito Y Exp Physiol; 2019 Jul; 104(7):1051-1060. PubMed ID: 31020720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]